BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28515958)

  • 1. Attitudes and preferences for the clinical management of hypertension and hypertension-related cerebrovascular disease in the general practice: results of the Italian hypertension and brain survey.
    Tocci G; Cicero AF; Salvetti M; Musumeci MB; Ferrucci A; Borghi C; Volpe M
    Clin Hypertens; 2017; 23():10. PubMed ID: 28515958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes and preferences for the clinical management of patients with hypertension and hypertension with chronic obstructive pulmonary disease in Italy: main results of a survey questionnaire.
    Tocci G; Cicero AF; Salvetti M; Passerini J; Musumeci MB; Ferrucci A; Borghi C; Volpe M
    Intern Emerg Med; 2015 Dec; 10(8):943-54. PubMed ID: 25986482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management of patients with hypertension and high cardiovascular risk in specialised centers and in general practice. Analysis from an Italian Survey Questionnaire.
    Tocci G; Palano F; Battistoni A; Citoni B; Musumeci MB; Ferrucci A; Borghi C; Volpe M
    Nutr Metab Cardiovasc Dis; 2015 Sep; 25(9):866-874. PubMed ID: 26093813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes and preferences for the clinical management of hypertension and hypertension-related cardiac disease in general practice: results of the Italian Hypertension and Heart Survey.
    Tocci G; Cicero AF; Salvetti M; Francia P; Ferrucci A; Borghi C; Volpe M
    J Hum Hypertens; 2015 Jul; 29(7):409-16. PubMed ID: 25518895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical management of patients with hypertension and high cardiovascular risk: main results of an Italian survey on blood pressure control.
    Tocci G; Borghi C; Volpe M
    High Blood Press Cardiovasc Prev; 2014 Jun; 21(2):107-17. PubMed ID: 24151125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Awareness of hypertension guidelines in primary care: results of a regionwide survey in Italy.
    Cuspidi C; Michev I; Meani S; Severgnini B; Sala C; Salerno M; Valerio C; Bertazzoli G; Leonetti G; Magrini F; Zanchetti A;
    J Hum Hypertens; 2003 Aug; 17(8):541-7. PubMed ID: 12874611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Strategies for improving blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. 2012 Position paper of the Italian Society of Hypertension].
    Volpe M; Ambrosioni E; Borghi C; Cottone S; Cuspidi C; De Luca N; Fallo F; Ferri C; Morganti A; Muiesan ML; Sarzani R; Sechi L; Virdis A; Tocci G; Agabiti-Rosei E; Trimarco B; Filippi A; Mancia G;
    G Ital Cardiol (Rome); 2012 Dec; 13(12):853-60. PubMed ID: 23196689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
    Khan NA; Hemmelgarn B; Padwal R; Larochelle P; Mahon JL; Lewanczuk RZ; McAlister FA; Rabkin SW; Hill MD; Feldman RD; Schiffrin EL; Campbell NR; Logan AG; Arnold M; Moe G; Campbell TS; Milot A; Stone JA; Jones C; Leiter LA; Ogilvie RI; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; Burns KD; Ruzicka M; deChamplain J; Pylypchuk G; Gledhill N; Petrella R; Boulanger JM; Trudeau L; Hegele RA; Woo V; McFarlane P; Touyz RM; Tobe SW;
    Can J Cardiol; 2007 May; 23(7):539-50. PubMed ID: 17534460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.
    Khan NA; McAlister FA; Rabkin SW; Padwal R; Feldman RD; Campbell NR; Leiter LA; Lewanczuk RZ; Schiffrin EL; Hill MD; Arnold M; Moe G; Campbell TS; Herbert C; Milot A; Stone JA; Burgess E; Hemmelgarn B; Jones C; Larochelle P; Ogilvie RI; Houlden R; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; Dechamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Tobe S; Touyz RM;
    Can J Cardiol; 2006 May; 22(7):583-93. PubMed ID: 16755313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family physicians' and general practitioners' approaches to drug management of diabetic hypertension in primary care.
    Al Khaja KA; Sequeira RP; Mathur VS; Damanhori AH; Abdul Wahab AW
    J Eval Clin Pract; 2002 Feb; 8(1):19-30. PubMed ID: 11882098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hypertension and stroke prevention: results of the Italian cardiologist survey.
    Tocci G; Giovannelli F; Sciarretta S; Ferrucci A; Zito GB; Volpe M
    Int J Clin Pract; 2009 Feb; 63(2):207-16. PubMed ID: 19196359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy. Scientific Committee of the Italian Pharmacoepidemiological Survey on Antihypertensive Therapy.
    Ambrosioni E; Leonetti G; Pessina AC; Rappelli A; Trimarco B; Zanchetti A
    J Hypertens; 2000 Nov; 18(11):1691-9. PubMed ID: 11081785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of fosinopril on progression of the asymptomatic carotid atherosclerosis and left ventricular hypertrophy in hypertensive patients].
    Tasić IS; Mijalković D; Djordjević D; Lović B; Janković D; Miladinović-Tasić N; Lović M
    Srp Arh Celok Lek; 2006; 134(3-4):106-13. PubMed ID: 16915750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A; Divchev D; Luchtefeld M; Schieffer B
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The benefit of angiotensin AT1 receptor blockers for early treatment of hypertensive patients.
    Trimarco B; Santoro C; Pepe M; Galderisi M
    Intern Emerg Med; 2017 Dec; 12(8):1093-1099. PubMed ID: 28770426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical treatment of hypertension in Switzerland. The 2009 Swiss Hypertension Survey (SWISSHYPE).
    Brenner R; Waeber B; Allemann Y
    Swiss Med Wkly; 2011; 141():w13169. PubMed ID: 21374529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.